Home
>
US Stocks
>
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
TSHA

Taysha Gene Therapies Inc

$17.623.08%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
17.22
Today Low/High
17.22 / 18.25
52 Week Low/High
$15.5 / $33.35
Market Cap
$663.56M

Company Details

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, Taysha aims to rapidly translate our treatments from bench to bedside. Taysha Gene Therapies has combined its team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, Taysha Gene Therapies leverages its fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives.
Organisation
Taysha Gene Therapies Inc
Employees
38
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Taysha Gene Therapies Inc share price today

Can Indians buy Taysha Gene Therapies Inc shares?

How can I buy Taysha Gene Therapies Inc shares from India?

Can Fractional shares of Taysha Gene Therapies Inc be purchased?

What are the documents required to start investing in Taysha Gene Therapies Inc stocks?

We are a SEBI registered investement advisor